Hyperthermia Influences the Secretion Signature of Tumor Cells and Affects Endothelial Cell Sprouting

Tumors are a highly heterogeneous mass of tissue showing distinct therapy responses. In particular, the therapeutic outcome of tumor hyperthermia treatments has been inconsistent, presumably due to tumor versus endothelial cell cross-talks related to the treatment temperature and the tumor tissue en...

Full description

Bibliographic Details
Main Authors: Wisdom O. Maduabuchi, Felista L. Tansi, Regine Heller, Ingrid Hilger
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/8/2256
_version_ 1797585365575401472
author Wisdom O. Maduabuchi
Felista L. Tansi
Regine Heller
Ingrid Hilger
author_facet Wisdom O. Maduabuchi
Felista L. Tansi
Regine Heller
Ingrid Hilger
author_sort Wisdom O. Maduabuchi
collection DOAJ
description Tumors are a highly heterogeneous mass of tissue showing distinct therapy responses. In particular, the therapeutic outcome of tumor hyperthermia treatments has been inconsistent, presumably due to tumor versus endothelial cell cross-talks related to the treatment temperature and the tumor tissue environment. Here, we investigated the impact of the average or strong hyperthermic treatment (43 °C or 47 °C for 1 h) of the human pancreatic adenocarcinoma cell line (PANC-1 and BxPC-3) on endothelial cells (HUVECs) under post-treatment normoxic or hypoxic conditions. Immediately after the hyperthermia treatment, the distinct repression of secreted pro-angiogenic factors (e.g., VEGF, PDGF-AA, PDGF-BB, M-CSF), intracellular HIF-1α and the enhanced phosphorylation of ERK1/2 in tumor cells were detectable (particularly for strong hyperthermia, 2D cell monolayers). Notably, there was a significant increase in endothelial sprouting when 3D self-organized pancreatic cancer cells were treated with strong hyperthermia and the post-treatment conditions were hypoxic. Interestingly, for the used treatment temperatures, the intracellular HIF-1α accumulation in tumor cells seems to play a role in MAPK/ERK activation and mediator secretion (e.g., VEGF, PDGF-AA, Angiopoietin-2), as shown by inhibition experiments. Taken together, the hyperthermia of pancreatic adenocarcinoma cells in vitro impacts endothelial cells under defined environmental conditions (cell-to-cell contact, oxygen status, treatment temperature), whereby HIF-1α and VEGF secretion play a role in a complex context. Our observations could be exploited for the hyperthermic treatment of pancreatic cancer in the future.
first_indexed 2024-03-11T00:06:01Z
format Article
id doaj.art-0bff461abe674b299b83c5eecf039c89
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-11T00:06:01Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-0bff461abe674b299b83c5eecf039c892023-11-19T00:21:34ZengMDPI AGBiomedicines2227-90592023-08-01118225610.3390/biomedicines11082256Hyperthermia Influences the Secretion Signature of Tumor Cells and Affects Endothelial Cell SproutingWisdom O. Maduabuchi0Felista L. Tansi1Regine Heller2Ingrid Hilger3Department of Experimental Radiology, Institute of Diagnostic and Interventional Radiology, Jena University Hospital—Friedrich Schiller University Jena, Am Klinikum 1, D-07747 Jena, GermanyDepartment of Experimental Radiology, Institute of Diagnostic and Interventional Radiology, Jena University Hospital—Friedrich Schiller University Jena, Am Klinikum 1, D-07747 Jena, GermanyInstitute of Molecular Cell Biology, Center for Molecular Biomedicine (CMB), Hans-Knöll-Str. 2, D-07745 Jena, GermanyDepartment of Experimental Radiology, Institute of Diagnostic and Interventional Radiology, Jena University Hospital—Friedrich Schiller University Jena, Am Klinikum 1, D-07747 Jena, GermanyTumors are a highly heterogeneous mass of tissue showing distinct therapy responses. In particular, the therapeutic outcome of tumor hyperthermia treatments has been inconsistent, presumably due to tumor versus endothelial cell cross-talks related to the treatment temperature and the tumor tissue environment. Here, we investigated the impact of the average or strong hyperthermic treatment (43 °C or 47 °C for 1 h) of the human pancreatic adenocarcinoma cell line (PANC-1 and BxPC-3) on endothelial cells (HUVECs) under post-treatment normoxic or hypoxic conditions. Immediately after the hyperthermia treatment, the distinct repression of secreted pro-angiogenic factors (e.g., VEGF, PDGF-AA, PDGF-BB, M-CSF), intracellular HIF-1α and the enhanced phosphorylation of ERK1/2 in tumor cells were detectable (particularly for strong hyperthermia, 2D cell monolayers). Notably, there was a significant increase in endothelial sprouting when 3D self-organized pancreatic cancer cells were treated with strong hyperthermia and the post-treatment conditions were hypoxic. Interestingly, for the used treatment temperatures, the intracellular HIF-1α accumulation in tumor cells seems to play a role in MAPK/ERK activation and mediator secretion (e.g., VEGF, PDGF-AA, Angiopoietin-2), as shown by inhibition experiments. Taken together, the hyperthermia of pancreatic adenocarcinoma cells in vitro impacts endothelial cells under defined environmental conditions (cell-to-cell contact, oxygen status, treatment temperature), whereby HIF-1α and VEGF secretion play a role in a complex context. Our observations could be exploited for the hyperthermic treatment of pancreatic cancer in the future.https://www.mdpi.com/2227-9059/11/8/2256hyperthermiapancreatic ductal adenocarcinoma (PDAC)endothelial cells (EC)sprouting angiogenesisvascular endothelial growth factor (VEGF)extracellular signal-regulated kinase (ERK)
spellingShingle Wisdom O. Maduabuchi
Felista L. Tansi
Regine Heller
Ingrid Hilger
Hyperthermia Influences the Secretion Signature of Tumor Cells and Affects Endothelial Cell Sprouting
Biomedicines
hyperthermia
pancreatic ductal adenocarcinoma (PDAC)
endothelial cells (EC)
sprouting angiogenesis
vascular endothelial growth factor (VEGF)
extracellular signal-regulated kinase (ERK)
title Hyperthermia Influences the Secretion Signature of Tumor Cells and Affects Endothelial Cell Sprouting
title_full Hyperthermia Influences the Secretion Signature of Tumor Cells and Affects Endothelial Cell Sprouting
title_fullStr Hyperthermia Influences the Secretion Signature of Tumor Cells and Affects Endothelial Cell Sprouting
title_full_unstemmed Hyperthermia Influences the Secretion Signature of Tumor Cells and Affects Endothelial Cell Sprouting
title_short Hyperthermia Influences the Secretion Signature of Tumor Cells and Affects Endothelial Cell Sprouting
title_sort hyperthermia influences the secretion signature of tumor cells and affects endothelial cell sprouting
topic hyperthermia
pancreatic ductal adenocarcinoma (PDAC)
endothelial cells (EC)
sprouting angiogenesis
vascular endothelial growth factor (VEGF)
extracellular signal-regulated kinase (ERK)
url https://www.mdpi.com/2227-9059/11/8/2256
work_keys_str_mv AT wisdomomaduabuchi hyperthermiainfluencesthesecretionsignatureoftumorcellsandaffectsendothelialcellsprouting
AT felistaltansi hyperthermiainfluencesthesecretionsignatureoftumorcellsandaffectsendothelialcellsprouting
AT regineheller hyperthermiainfluencesthesecretionsignatureoftumorcellsandaffectsendothelialcellsprouting
AT ingridhilger hyperthermiainfluencesthesecretionsignatureoftumorcellsandaffectsendothelialcellsprouting